Synergistic Role of Biofilm-Associated Genes and Efflux Pump Genes in Tigecycline Resistance of Acinetobacter baumannii.
Journal
Medical science monitor : international medical journal of experimental and clinical research
ISSN: 1643-3750
Titre abrégé: Med Sci Monit
Pays: United States
ID NLM: 9609063
Informations de publication
Date de publication:
09 Sep 2023
09 Sep 2023
Historique:
medline:
11
9
2023
pubmed:
9
9
2023
entrez:
9
9
2023
Statut:
epublish
Résumé
BACKGROUND Previous research reported that the resistance mechanism of Acinetobacter baumannii resistance to tigecycline was mainly related to the overexpression of the AdeABC efflux pump system. Biofilm formation is a notable pathogenesis of A. baumannii infections and antibiotic resistance. Our study explores the latent relevance of biofilm-associated genes and efflux pump genes in A. baumannii tigecycline resistance. MATERIAL AND METHODS A total of 78 clinical samples were collected from October 2018 to October 2019. Seventy-two clinically isolated A. baumannii strains were divided into a tigecycline-resistant Acinetobacter baumannii (TR-AN) group and tigecycline-sensitive Acinetobacter baumannii (TS-AN) group by tigecycline minimum inhibitory concentration tests. The biofilm formation of the 2 groups was observed using crystal violet staining. Furthermore, biofilm-related genes and efflux pump genes were analyzed by RT-PCR. RESULTS The biofilm-forming rate of the TR-AN group was 82.2%, and that of the TS-AN group was 14.8%. The biofilm synthesis gene bfs was 91.3% positive in the TR-AN group, significantly higher than in the TS-AN group at the transcription level (P<0.05). The minimum inhibitory concentration of tigecycline was higher in the TR-AN group with biofilm formation than in the TR-AN group without biofilm formation (P<0.05). The efflux pump AdeB gene was 95.2% positive in the TR-AN group with biofilm formation and 38.7% positive in the TR-AN group without biofilm formation. CONCLUSIONS The biofilm formation of A. baumannii may be positively related to tigecycline resistance ability because of the co-expression of the bfs gene and the AdeB efflux pump gene. The enhanced transcription level of bfs and AdeB promotes biofilm formation to improve the resistance of A. baumannii to tigecycline.
Identifiants
pubmed: 37688296
pii: 940704
doi: 10.12659/MSM.940704
pmc: PMC10498786
doi:
Substances chimiques
Tigecycline
70JE2N95KR
Gentian Violet
J4Z741D6O5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e940704Références
J Environ Sci Health A Tox Hazard Subst Environ Eng. 2021;56(2):213-225
pubmed: 33378222
Pathogens. 2020 Aug 02;9(8):
pubmed: 32748817
Infect Drug Resist. 2019 Dec 12;12:3867-3881
pubmed: 31853190
Antibiotics (Basel). 2020 Dec 26;10(1):
pubmed: 33375352
Infect Prev Pract. 2020 Jul 19;2(3):100077
pubmed: 34368717
Sci Rep. 2019 Feb 19;9(1):2267
pubmed: 30783197
Antibiotics (Basel). 2021 Aug 25;10(9):
pubmed: 34572620
BMC Infect Dis. 2020 Mar 30;20(1):253
pubmed: 32228597
Viruses. 2021 Dec 24;14(1):
pubmed: 35062236
J Antimicrob Chemother. 2017 Jan;72(1):172-180
pubmed: 27650184
Antimicrob Agents Chemother. 2016 Jul 22;60(8):4670-6
pubmed: 27216052
Infect Drug Resist. 2019 May 07;12:1099-1111
pubmed: 31190904
J Infect Dev Ctries. 2020 Dec 31;14(12):1455-1460
pubmed: 33378290
Front Microbiol. 2020 Dec 14;11:591679
pubmed: 33381089
J Glob Antimicrob Resist. 2021 Sep;26:1-3
pubmed: 34020074
Rev Soc Bras Med Trop. 2020 Nov 13;54:e20200087
pubmed: 33206875
Semin Respir Crit Care Med. 2017 Jun;38(3):311-325
pubmed: 28578555
Cureus. 2021 Dec 6;13(12):e20220
pubmed: 35004039
Ann Clin Microbiol Antimicrob. 2018 Jun 1;17(1):24
pubmed: 29859115
BMC Infect Dis. 2021 Aug 20;21(1):841
pubmed: 34416851
Microbiologyopen. 2020 Sep;9(9):e1063
pubmed: 32700454
Saudi J Biol Sci. 2021 Jan;28(1):1158-1166
pubmed: 33424412
Infect Dis Ther. 2021 Mar;10(1):411-420
pubmed: 33483853
Ann Trop Med Parasitol. 2011 Jul;105(5):359-65
pubmed: 21929877
Infect Drug Resist. 2018 Nov 15;11:2277-2299
pubmed: 30532562
Eur J Clin Microbiol Infect Dis. 2014 Dec;33(12):2141-7
pubmed: 24939621
Open Med (Wars). 2019 Oct 25;14:772-777
pubmed: 31667355
Curr Microbiol. 2021 Nov;78(11):3936-3944
pubmed: 34522977
J Hosp Infect. 2012 Jan;80(1):56-60
pubmed: 21975219
Microb Pathog. 2019 Mar;128:75-81
pubmed: 30562602
Lett Appl Microbiol. 2016 Oct;63(4):233-9
pubmed: 27479925
J Chemother. 2022 May;34(3):166-172
pubmed: 34818987
Diagn Mol Pathol. 2011 Dec;20(4):242-8
pubmed: 22089352
Molecules. 2019 May 14;24(10):
pubmed: 31091746
Mymensingh Med J. 2020 Jul;29(3):622-627
pubmed: 32844803
Crit Care. 2018 Nov 21;22(1):319
pubmed: 30463589
Infect Drug Resist. 2021 Sep 10;14:3711-3719
pubmed: 34531666
Microbiol Spectr. 2021 Oct 31;9(2):e0101021
pubmed: 34523993
Biofouling. 2020 Aug;36(7):753-765
pubmed: 32847400
J Clin Microbiol. 2021 Nov 18;59(12):e0021321
pubmed: 34550809
J Chemother. 2021 Jul;33(4):203-215
pubmed: 32875967
Microorganisms. 2021 Nov 16;9(11):
pubmed: 34835490
Future Microbiol. 2015;10(3):337-46
pubmed: 25812457
Rev Inst Med Trop Sao Paulo. 2020 Nov 13;62:e88
pubmed: 33206862
Saudi J Biol Sci. 2021 Mar;28(3):1750-1756
pubmed: 33732058
J Reprod Fertil. 1967 Feb;13(1):41-50
pubmed: 6066780
PeerJ. 2020 May 28;8:e9020
pubmed: 32523805
BMC Biol. 2021 Dec 11;19(1):262
pubmed: 34895224
J Antimicrob Chemother. 2007 May;59(5):1001-4
pubmed: 17363424
Front Genet. 2020 Dec 22;11:601380
pubmed: 33414809
Nat Commun. 2019 Sep 30;10(1):4283
pubmed: 31570766
PLoS One. 2017 Apr 7;12(4):e0175140
pubmed: 28388651
Front Microbiol. 2019 Dec 11;10:2849
pubmed: 31921031
Pharmaceutics. 2021 Dec 24;14(1):
pubmed: 35056926